ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE..................................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0619836A119941019EP93900825.01992120119940603enenen1991080179419911202US1994101919944219941019199442

C12N 5/ 00 A I

C07K 14/ 71 A I

C12N 1/ 21 A I

C12N 5/ 10 A I

C12N 15/ 09 A I

C12P 21/ 02 A I

A61K 38/ 00 A N

C12R 1/ 91 A N

enMETHODS FOR PRODUCTION OF PURIFIED SOLUBLE TYPE B AND TYPE A HUMAN PLATELET-DERIVED GROWTH FACTOR RECEPTOR FRAGMENTSfrPROCEDES DE PRODUCTION DE FRAGMENTS SOLUBLES PURIFIES RECEPTEURS DU FACTEUR DE CROISSANCE DERIVE DES PLAQUETTES HUMAINES DU TYPE A ET BdeMETHODEN ZUR HERSTELLUNG VON GEREINIGTEN, LÖSLICHEN PDGF-REZEPTORFRAGMENTEN VOM TYP-A UND TYP-B AUS MENSCHCOR THERAPEUTICS, INC.256 East Grand Avenue, Suite 80South San Francisco, CA 94080USWOLF, David2142 Belview DrivePalo Alto, CA 94303USTOMLINSON, James, E.1540 Balboa StreetBurlingame, CA 94010USThomson, Paul AnthonyPotts, Kerr & Co. 15, Hamilton SquareBirkenhead Merseyside L41 6BRGBATBECHDEDKESFRGBGRIEITLILUMCNLPTSEUS199201043019921201enWO199301122319930610199314